| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | OceanaGold begins trading on New York Stock Exchange | ||
| Di | Anthropic launches Project Glasswing to secure critical software | ||
| Di | Mattel names Sanjay Luthra as chief commercial officer | ||
| Di | Paylocity stock: Needham maintains Buy on AI recruiting deal | ||
| Di | Jefferies cuts Arhaus stock price target on Iran conflict concerns | ||
| Di | AMTD chairman joins HKUST Guangzhou advisory board | ||
| Di | Raymond James raises Charles Schwab stock price target on rates | ||
| Di | CleanSpark reports March bitcoin production, treasury activity | ||
| Di | TransDigm completes $2.2B aerospace parts acquisition | ||
| Di | Barclays to redeem A$250m debt instruments in May | ||
| Di | Gamma Communications confirms takeover discussions | ||
| Di | Abeona Therapeutics names Keith Goldan to board of directors | ||
| Di | Vivos Therapeutics closes $2.25M private placement with Seneca | ||
| Di | Cemtrex subsidiary wins Navy contract for mine warfare tech | ||
| Di | Azenta names Trey Martin president of Multiomics business | ||
| Di | EnWave signs R&D license with chef Dan Barber's Rhizome | ||
| Di | Xenon Pharmaceuticals to present azetukalner epilepsy data at AAN | ||
| Di | RedCloud appoints Mustafa Ergen to board amid Turkey expansion | ||
| Di | SecureTech Innovations nominates Robert Castro to board | ||
| Di | BioRestorative partners with 203 Creates for skincare brand launch | ||
| Di | William Blair downgrades Terns Pharmaceuticals stock rating on Merck deal | ||
| Di | ASML executes €100 million in share buybacks over four days | ||
| Di | Jupiter Neurosciences adds advisors for consumer product expansion | ||
| Di | Evaxion completes phase 2 trial extension for cancer vaccine | ||
| Di | Halozyme licenses Hypercon technology to Vertex for $15M |